Abstract:Objective To explore effect of interleukin 10(IL-10)gene-modified bone marrowderived liver stem cells(BDLSCs)transplantation on hepatic inflammatory response and liver regeneration in rats with Iiver fibrosis.Methods 50 female Wistar rats were randomly devided into 4 groups:(1)control group:10 rats were subcutaneously injected with olive oil for 8 weeks;(2)fibrosis groups:16 rats were subcutaneously injected with carbon tetrachloride(CCl_4)for 8 weeks to induce liver fibrosis;(3)BDLSC group:12 rats were subcutaneously injected with CCl_4 for 8 weeks,and were transplanted with 2 × 10~5 BDLSC at week 4;(4)BDLSC/IL-10 group:12 rats were subcutaneously injected with CCl_4 for 8 weeks,and were transplanted with 2×10~5 IL-10 gene-modified BDLSC at week 4.IL-10 and tumor necrosis factor alpha(TNF α)in liver tissues were detected by ELISA.HE stained liver tissues were observed under light microscope.The expression of hepatocyte growth factor(HGF)was quantified by real-time RT-PCR,and the expression of proliferating cell nuclear antigen (PCNA) was determined by immunohistochemistry.Results The ratio of IL-10/TNF α in fibrosis group(0.05±0.01)was lowerthan thatin control group(0.26±0.04)(P<0.01).Transplantation of untreated BDLSCs did not improve the ratio(P>0.05),however,transplantation of IL-10 modified BDLSCs improved the ratio significantly (P<0.01).Severe inflammatory response and fibrosis were observed in fibrosis group.Inflammatory response was alleviated to some extent in the BDLSC group,and the histopathology of BDLSC/IL-10 group was not significantly different from that of the control group.Comparedtothe control group,the expression of HGF mRNA and PCNA protein was increased in the fibrosis group(P<0.01).The expression of HGF and PCNA was further increased by BDLSCs or IL-10 modified BDLSCs transplantation.Compared to BDLSCs.IL-10 gene-modified BDLSCs were more potent to induce the expression of HGF and PCNA.Conclusion Transplantation of IL-10 gene-modified BDLSCs can alleviate hepatic inflammatory response and promote liver regeneration in hepatic fibrosis rats.

Interleukin-10 and Liver Diseases

Immune Therapy of Interleukin-10 in Heart Transplantation

Expression of interleukin-10 in the liver tissues of patients with chronic liver diseases of different etiologies

Interleukins in liver disease treatment

Interleukin 22 in Liver Injury, Inflammation and Cancer

The Role of IL-35 in the Pathophysiological Processes of Liver Disease

Antifibrotic Effects of Interleukin-10 on Experimental Hepatic Fibrosis.

Expression of IL-10 in the livers of rats with chronic alcoholic liver diseases]

Physiological and Pathological Properties of Interleukin-22 in Liver Diseases

Effect of Interleukin-10 on the Phenotype and Function of Cultured Human Dendritic Cells.

[Downregulation of Transforming Growth Factor-Beta1 and Platelet-Derived Growth Factor Gene Expression by Interleukin-10 in Murine Hepatic Stellate Cells in Response to Experimental Liver Injury].

The role of interleukin -1 family in fibrotic diseases

Research Progress in Association Between Interleukin-23 and Liver Diseases

The Role Of Il-1 Family Members And Kupffer Cells In Liver Regeneration

Interleukin-10 Protects Dopaminergic Neurons by Inhibiting Generation of Proinflammatory Factors

Effect of interleukin 10 gene-modified bone marrow-derived liver stem cells transplantation on hepatic inflammatory response and liver regeneration in hepatic fibrosis rats

Interleukin-1o and Psoriasis

Interleukin-10 family members: Biology and role in the bone and joint diseases

The Role of Interferon Regulatory Factors in Liver Diseases

Epigenetic Changes Associated With Interleukin-10

Differences of Liver CD4+CD25+Foxp3+regulatory T Cells in Mice with Acute and Chronic Liver Injury